InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Hutt Peter Barton. Director active across 1 company, notably Concert Pharmaceuticals, INC.. In total, 5 reports have been published. Split: 0 buy · 1 sell. Total volume traded: €22k. Activity tracked since 14 October 2022. The latest transaction was filed on 14 October 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Hutt Peter Barton
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
13,088 sharesCommon StockSEC:0001209191-23-016165:0
3,539 shares@ US$2.8832.1% of flowCommon StockSEC:0001209191-22-053967:0
3,539 shares@ US$6.0967.9% of flowCommon StockSEC:0001209191-22-053967:1
16,400 sharesCommon StockSEC:0001209191-22-036288:0
5,125 sharesCommon StockSEC:0001209191-21-039746:0
5 of 5 declarations
About Hutt Peter Barton
HUTT PETER BARTON is a declarant linked to Concert Pharmaceuticals, INC., where he is a Director. Across 6 filings in total, the 6 sampled filings run from 2021-06-11 to 2023-03-06 and show EUR 0 of purchases and EUR 22102 of sales, with the modal transaction nature listed as Attribution.
